Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Recruiting · NCT05908682 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes | Bacterial Infections and Mycoses, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Stomatognathic Diseases, Urogenital Diseases, candidiasis, female reproductive system disorder, fungal infectious disease, mouth disorder, oral candidiasis, vaginal disorder, vaginitis, vulvar disease, vulvitis, vulvovaginal candidiasis, vulvovaginitis | Recruiting | Not stated | 2026-09-23 | NCT05908682 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AWINSA | New Delhi | India | 1 |